TrialClinical pharmacology and therapeutics2022

Vericiguat in Combination with Short-Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE Study.

Michael Boettcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.